It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Revenue Generation in Pharma-DTx Partnerships

11th January @ 10:45AM EDT

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. However, lessons have been learnt and the hype has died down as ROI and outcomes did not meet the initial expectations held by pharma. 

As we enter a new phase where pharma’s approach to DTx has matured and results need to be shown, how can pharma build more effective revenue models when partnering with DTx companies? What is involved in this process? Join this meeting to know more about:

  • Current effective models for revenue generation.  What has worked and what hasn't? How have the revenue models evolved over the past few years? 
  • Revenue generation in the short and long term. How can DTx and pharma generate revenue in the short term to show the potential of a longer term partnership? How should the revenue models change over time to support both short and long term goals?
  • Measuring ROI in Pharma-DTx partnerships. How challenging is it to measure the ROI in Pharma-DTx partnerships? What would be an ‘acceptable’ ROI for pharma? And what are the ‘acceptable’ timelines to reach the desired ROI? 
  • Future opportunities for higher revenue in pharma-DTx partnerships. Where in the pharma value chain will we see more opportunities for higher revenue partnerships? What are the technologies and therapeutic areas with more potential for pharma? 
  • Future revenue models. What will revenue generation look like for DTx-Pharma partnerships in a few years time? What is driving this? Will DTx partnerships offer attractive revenue potential to pharma companies?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Revenue Generation in Pharma-DTx Partnerships

Ronny Hashmonay
Global Head of Business Transformation at Novartis
Anish Shindore
Founder & Managing Partner, GSD Health

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

11th January @ 10:45AM EDT

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. However, lessons have been learnt and the hype has died down as ROI and outcomes did not meet the initial expectations held by pharma. 

As we enter a new phase where pharma’s approach to DTx has matured and results need to be shown, how can pharma build more effective revenue models when partnering with DTx companies? What is involved in this process? Join this meeting to know more about:

  • Current effective models for revenue generation.  What has worked and what hasn't? How have the revenue models evolved over the past few years? 
  • Revenue generation in the short and long term. How can DTx and pharma generate revenue in the short term to show the potential of a longer term partnership? How should the revenue models change over time to support both short and long term goals?
  • Measuring ROI in Pharma-DTx partnerships. How challenging is it to measure the ROI in Pharma-DTx partnerships? What would be an ‘acceptable’ ROI for pharma? And what are the ‘acceptable’ timelines to reach the desired ROI? 
  • Future opportunities for higher revenue in pharma-DTx partnerships. Where in the pharma value chain will we see more opportunities for higher revenue partnerships? What are the technologies and therapeutic areas with more potential for pharma? 
  • Future revenue models. What will revenue generation look like for DTx-Pharma partnerships in a few years time? What is driving this? Will DTx partnerships offer attractive revenue potential to pharma companies?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participants

Participants

Ronny Hashmonay

Global Head of Business Transformation at Novartis

Anish Shindore

Founder & Managing Partner, GSD Health

Jorge Juan Fernández García

Director of Innovation, EIT Health

Fulvio Michelis, PhD

Digital Strategy Director, Merck Group

Ran Ken-Tor

CEO, DermaDetect

Carman Ho

Vice President, L1 Health

Ivan Jurisic

Business Analyst for Digital Therapeutics at Roche

Mirza Ahmed

Senior Director, Hikma Pharmaceuticals

Ashley Pippin

Director, Digital Product Delivery, Novartis Biome

Nita Thingalaya

US Digital Health Care Medical Director, Sanofi

Rick Bartels

Managing Partner , DTxCC

Arshia Gratiot

Founder and CEO, Eupnoos

Katie Cannon

Head of Growth, Avegen

Philipp Unruh

Digital Product Manager, Bayer

Ventsislav Dobrev

Global Innovation & Digital Health Solutions Manager, Ypsomed

Marko Kuisma

Partner, Innovestor Life Science Fund

Number of Participants


Up to 12
Date  
January 11, 2023
Community

Revenue Generation in Pharma-DTx Partnerships

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. However, lessons have been learnt and the hype has died down as ROI and outcomes did not meet the initial expectations held by pharma. 

As we enter a new phase where pharma’s approach to DTx has matured and results need to be shown, how can pharma build more effective revenue models when partnering with DTx companies? What is involved in this process? Join this meeting to know more about:

  • Current effective models for revenue generation.  What has worked and what hasn't? How have the revenue models evolved over the past few years? 
  • Revenue generation in the short and long term. How can DTx and pharma generate revenue in the short term to show the potential of a longer term partnership? How should the revenue models change over time to support both short and long term goals?
  • Measuring ROI in Pharma-DTx partnerships. How challenging is it to measure the ROI in Pharma-DTx partnerships? What would be an ‘acceptable’ ROI for pharma? And what are the ‘acceptable’ timelines to reach the desired ROI? 
  • Future opportunities for higher revenue in pharma-DTx partnerships. Where in the pharma value chain will we see more opportunities for higher revenue partnerships? What are the technologies and therapeutic areas with more potential for pharma? 
  • Future revenue models. What will revenue generation look like for DTx-Pharma partnerships in a few years time? What is driving this? Will DTx partnerships offer attractive revenue potential to pharma companies?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participate in the Meeting

HealthXL Meetings

HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.

Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.

Digital Health Meetings are fully interactive and promote conversation - be ready to talk!

Participant-Led

HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.

Developed for a Busy Schedule

No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.

A Community to connect and network

Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.

continueD learning

Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.

Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Commentary
January 26, 2023
Innovation in Pharma: Friend or Foe? (Part 1)
Innovation in Pharma: Friend or Foe? (Part 1)
Read More
Commentary
January 24, 2023
3 Big News Stories from January
3 Big News Stories from January
Read More
Commentary
January 17, 2023
Digital Health 2022: Highlights
Digital Health 2022: Highlights
Read More

Frequently Asked Questions

What is a HealthXL Digital Health Meeting?

HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.

read more
view Less

How can I become a member of the Digital Health Community?

We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.

read more
view Less

When can I access the Meeting recording?

Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.

read more
view Less

I am participating in this meeting, but can't attend anymore. Can I cancel it?

It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.

read more
view Less

Revenue Generation in Pharma-DTx Partnerships

11th January @ 10:45AM EDT
Digital Therapeutics (DTx)

Revenue Generation in Pharma-DTx Partnerships

11th January @ 10:45AM EDT
Digital Therapeutics (DTx)
Ronny Hashmonay
Global Head of Business Transformation at Novartis
LinkedIn Profile
Anish Shindore
Founder & Managing Partner, GSD Health
LinkedIn Profile
Jorge Juan Fernández García
Director of Innovation, EIT Health
LinkedIn Profile
Fulvio Michelis, PhD
Digital Strategy Director, Merck Group
LinkedIn Profile
Ran Ken-Tor
CEO, DermaDetect
LinkedIn Profile
Carman Ho
Vice President, L1 Health
LinkedIn Profile
Ivan Jurisic
Business Analyst for Digital Therapeutics at Roche
LinkedIn Profile
Mirza Ahmed
Senior Director, Hikma Pharmaceuticals
LinkedIn Profile
Ashley Pippin
Director, Digital Product Delivery, Novartis Biome
LinkedIn Profile
Nita Thingalaya
US Digital Health Care Medical Director, Sanofi
LinkedIn Profile
Rick Bartels
Managing Partner , DTxCC
LinkedIn Profile
Arshia Gratiot
Founder and CEO, Eupnoos
LinkedIn Profile
Katie Cannon
Head of Growth, Avegen
LinkedIn Profile
Philipp Unruh
Digital Product Manager, Bayer
LinkedIn Profile
Ventsislav Dobrev
Global Innovation & Digital Health Solutions Manager, Ypsomed
LinkedIn Profile
Marko Kuisma
Partner, Innovestor Life Science Fund
LinkedIn Profile

Revenue Generation in Pharma-DTx Partnerships

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. However, lessons have been learnt and the hype has died down as ROI and outcomes did not meet the initial expectations held by pharma. 

As we enter a new phase where pharma’s approach to DTx has matured and results need to be shown, how can pharma build more effective revenue models when partnering with DTx companies? What is involved in this process? Join this meeting to know more about:

  • Current effective models for revenue generation.  What has worked and what hasn't? How have the revenue models evolved over the past few years? 
  • Revenue generation in the short and long term. How can DTx and pharma generate revenue in the short term to show the potential of a longer term partnership? How should the revenue models change over time to support both short and long term goals?
  • Measuring ROI in Pharma-DTx partnerships. How challenging is it to measure the ROI in Pharma-DTx partnerships? What would be an ‘acceptable’ ROI for pharma? And what are the ‘acceptable’ timelines to reach the desired ROI? 
  • Future opportunities for higher revenue in pharma-DTx partnerships. Where in the pharma value chain will we see more opportunities for higher revenue partnerships? What are the technologies and therapeutic areas with more potential for pharma? 
  • Future revenue models. What will revenue generation look like for DTx-Pharma partnerships in a few years time? What is driving this? Will DTx partnerships offer attractive revenue potential to pharma companies?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

When:
11th January @ 10:45AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.